Cachet Pharmaceuticals Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Cachet Pharmaceuticals Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $538.7K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Cachet Pharmaceuticals Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $538.7K Trade | TransData Nexus

Cachet Pharmaceuticals Private Limited

Indian Pharmaceutical Exporter · Respiratory & OTC Specialist · $538.7K Total Trade · DGFT Verified

Cachet Pharmaceuticals Private Limited is an Indian pharmaceutical exporter with a total trade value of $538.7K across 2 products in 2 therapeutic categories. Based on 96 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Dextromethorphan ($286.1K), Ornidazole ($252.6K), .

Cachet Pharmaceuticals Private Limited — Export Portfolio & Destination Treemap

Cachet Pharmaceuticals Private Limited pharmaceutical export portfolio — 2 products across 2 therapeutic categories. Source: Indian Customs (DGFT).

Who is Cachet Pharmaceuticals Private Limited? — Company Overview & Market Position

Cachet Pharmaceuticals Private Limited, established in 1978, is a prominent Indian pharmaceutical company specializing in the manufacturing and marketing of a diverse range of pharmaceutical formulations and nutraceuticals. The company is headquartered in Patna, Bihar, India, with its registered office located at Exhibition Road, P.S.-Gandhi Maidan, Patna, Bihar 800001. Cachet operates as a private limited company, classified under the Corporate Identification Number (CIN) U24230BR1978PTC001328. The authorized capital stands at ₹40,00,000, with a paid-up capital of ₹17,83,400. The company employs a workforce of over 1,400 individuals, reflecting its significant presence in the pharmaceutical sector. Cachet's product portfolio encompasses various therapeutic segments, including antibiotics, NSAIDs, gastrointestinal agents, nutritional supplements, anti-osteoporosis medications, and gynecological products. Leading brands include Traxol, Traxol-S, Traxol-T, Lysoflam, NE, I-UP, Cavit-PM, PNZ, PNZ-D, Vitoc-D, Cadbe, Vitzin, Pamagin, P40, Moxate, Capritaz, Merotiva, and Cachpar.

What Does Cachet Pharmaceuticals Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Dextromethorphan$286.1K

Product Portfolio — Top 2 by Export Value

Cachet Pharmaceuticals Private Limited exports 2 pharmaceutical products across 2 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Dextromethorphan	Respiratory & OTC	$286.1K	54	1.9%	13
2	Ornidazole	Advanced Antibiotics	$252.6K	42	1.4%	6

Cachet Pharmaceuticals Private Limited exports 2 pharmaceutical products across 2 therapeutic categories with a total export value of $538.7K. The top category is Respiratory & OTC (53.1% of portfolio), followed by Advanced Antibiotics (46.9%), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Cachet Pharmaceuticals Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Cachet Pharmaceuticals operates two primary manufacturing facilities in India. The first is located in Bhiwadi, Rajasthan, covering an area of 65,000 square feet. This plant is equipped with state-of-the-art manufacturing facilities and has been certified by WHO-GMP and ISO 9001:2000. The second facility is situated in Baddi, Himachal Pradesh, and is designed to accommodate increased production capacity. Both plants are authorized by the FDA and WHO, ensuring compliance with international quality standards.

3Key Leadership

The leadership team at Cachet Pharmaceuticals comprises several key individuals:

Satish Kumar Singh: Managing Director, appointed on 16 June 2001.

Anuja Madhurendra Sinha: Director, appointed on 16 November 2015.

Arunkumar Dattatray Deshmukh: Director, appointed on 15 June 2015.

Premlata Singh: Director, appointed on 30 May 2019.

These leaders are responsible for steering the company's strategic direction and ensuring its growth and compliance with industry standards.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Cachet Pharmaceuticals Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Cachet Pharmaceuticals has established a presence in several regulated markets, including the United States, European Union, United Kingdom, and Australia. The company's manufacturing facilities in Bhiwadi and Baddi have been inspected and approved by the FDA and WHO, indicating compliance with international quality standards. While specific regulatory filings and approvals in these markets are not detailed in the available sources, the company's adherence to WHO-GMP and ISO 9001:2000 certifications suggests a commitment to meeting the stringent requirements of these regions.

2Emerging Markets

Cachet Pharmaceuticals has expanded its reach to over 30 countries, with more than 500 product registrations. This global footprint includes markets in Africa, Latin America, and Southeast Asia. The company's adherence to WHO-GMP standards facilitates access to these emerging markets, ensuring product quality and safety.

3Geographic Strategy

Cachet Pharmaceuticals demonstrates a diversified geographic strategy by operating in over 30 countries, including emerging markets in Africa, Latin America, and Southeast Asia. This broad international presence mitigates concentration risk and positions the company to leverage growth opportunities across different regions. The company's adherence to WHO-GMP standards further supports its strategic direction, ensuring product quality and facilitating market access.

Cachet Pharmaceuticals Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Cachet Pharmaceuticals' manufacturing facilities in Bhiwadi and Baddi have been inspected and approved by the FDA, indicating compliance with international quality standards. While specific details regarding FDA facility registrations, approved ANDAs, DMF filings, and inspection history are not provided in the available sources, the company's adherence to WHO-GMP and ISO 9001:2000 certifications suggests a commitment to meeting the stringent requirements of the FDA.

2WHO & EU GMP

Cachet Pharmaceuticals' manufacturing facilities are certified by WHO-GMP and ISO 9001:2000, reflecting compliance with international quality standards. While specific EU GMP certificates and EDQM status are not detailed in the available sources, the company's adherence to WHO-GMP standards suggests a commitment to meeting the stringent requirements of the European Union.

3CDSCO & Indian Regulatory

Cachet Pharmaceuticals holds manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO), ensuring compliance with Indian regulatory standards. The company's manufacturing facilities in Bhiwadi and Baddi are authorized by the FDA and WHO, indicating adherence to international quality standards. Specific details regarding state drug controller approvals and export No Objection Certificates (NOCs) are not provided in the available sources.

Cachet Pharmaceuticals Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Cachet Pharmaceuticals operates in a competitive landscape with several key players in the pharmaceutical industry. While specific competitors in overlapping categories are not detailed in the available sources, the company's diversified product portfolio and international presence position it to effectively compete in various therapeutic segments. The company's adherence to WHO-GMP and ISO 9001:2000 certifications further enhances its competitive standing by ensuring product quality and regulatory compliance.

2Key Differentiators

Cachet Pharmaceuticals' key differentiators include its diversified product portfolio covering multiple therapeutic segments, including pain management, gynecology, and anti-infectives. The company's manufacturing facilities are certified by WHO-GMP and ISO 9001:2000, reflecting compliance with international quality standards. Additionally, Cachet's global presence in over 30 countries and more than 500 product registrations demonstrate its ability to meet diverse market needs.

3Strategic Position

Cachet Pharmaceuticals is strategically positioned as a manufacturer and marketer of a wide range of pharmaceutical formulations and nutraceuticals. The company's diversified product portfolio spans acute and chronic therapies, including pain management, gynecology, and anti-infectives. With a global presence in over 30 countries and more than 500 product registrations, Cachet is well-positioned to leverage growth opportunities across diverse markets.

Buyer Due Diligence Brief — Evaluating Cachet Pharmaceuticals Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Cachet Pharmaceuticals has demonstrated a consistent track record in the pharmaceutical industry, with over four decades of experience. The company has consistently registered a turnover of over ₹400 crores in the preceding three financial years and is striving to achieve ₹1,000 crores in the coming years. The company's adherence to WHO-GMP and ISO 9001:2000 certifications reflects its commitment to maintaining high-quality manufacturing standards. Cachet's global presence in over 30 countries and more than 500 product registrations further underscores its reliability as a supplier.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and regulatory compliance:

WHO-GMP Certification: Indicates compliance with World Health Organization Good Manufacturing Practices.

ISO 9001:2000 Certification: Demonstrates adherence to international quality management standards.

These certifications can typically be verified through the company's official website or by contacting the company directly.

Frequently Asked Questions — Cachet Pharmaceuticals Private Limited

How many pharmaceutical products does Cachet Pharmaceuticals Private Limited export from India?

Cachet Pharmaceuticals Private Limited exports 2 pharmaceutical products across 2 therapeutic categories. The top exports are Dextromethorphan ($286.1K), Ornidazole ($252.6K). Total export value is $538.7K.

What is Cachet Pharmaceuticals Private Limited's total pharmaceutical export value?

Cachet Pharmaceuticals Private Limited's total pharmaceutical export value is $538.7K, based on 96 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Cachet Pharmaceuticals Private Limited cover?

Cachet Pharmaceuticals Private Limited exports across 2 therapeutic categories. The largest are Respiratory & OTC (53.1%, 1 products), Advanced Antibiotics (46.9%, 1 products).

Get Full Cachet Pharmaceuticals Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.